Announces that one of its clients is presenting results of Microbix made quality assessment products that help enable full-process quality management of molecular assays to detect human papillomavirus at 2026 PASCV. Microbix Biosystems Inc. shares T.MBX are trading up $0.01 at $0.25.
Stocks in play: Microbix Biosystems Inc.
Baystreet.ca - Baystreet - Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here